Brainstorm Cell Therapeutics reported $-0.19 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Biogen USD 2.62 0.98 Sep/2026
Brainstorm Cell Therapeutics USD -0.19 0 Mar/2026
Cipla INR 10.85 1.09 Sep/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.07 0.16 Jun/2026
CSL USD 5.07 3 Dec/2025
Cytokinetics USD -1.37 0.13 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
Grifols EUR 0.16 0.02 Mar/2026
Halozyme Therapeutics USD 2.39 0.11 Sep/2026
Mesoblast USD -0.01 0.02 Jun/2026